Adaptive Biotechnologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.

CEO

Chad Robins

CEOChad Robins

Employees

619

Employees619

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2009

Founded2009

Employees

619

Employees619

ADPT Key Statistics

Market cap

1.37B

Market cap1.37B

Price-Earnings ratio

-9.42

Price-Earnings ratio-9.42

Dividend yield

—

Dividend yield—

Average volume

3.95M

Average volume3.95M

High today

$9.41

High today$9.41

Low today

$9.02

Low today$9.02

Open price

$9.32

Open price$9.32

Volume

1.69M

Volume1.69M

52 Week high

$10.28

52 Week high$10.28

52 Week low

$2.99

52 Week low$2.99

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.